• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Study: Endovascular aneurysm repair shows higher long-term mortality

Study: Endovascular aneurysm repair shows higher long-term mortality

October 13, 2016 By Brad Perriello

EVAREndovascular repair of abdominal aortic aneurysms showed a higher mortality rate over the long term compared with open surgical repair, according to a study published yesterday in The Lancet.

The study, “Endovascular versus open repair of abdominal aortic aneurysm in 15-years’ follow-up of the UK endovascular aneurysm repair trial 1,” was based on data from the 1,252-patient Evar trial 1, in which 626 patients were randomly assigned to either EVAR using a stent graft or open surgical repair. The primary endpoint was total and aneurysm-related deaths through mid-2015.

The EVAR cohort showed a 42% lower mortality rate after 6 months, likely due to lower complication rates. There was no mortality difference between the techniques from 6 months to 8 years, but from 8 to 15 years the EVAR group showed a 14% mortality increase compared with the open surgery group.

“The increased aneurysm-related mortality in the EVAR group after 8 years was mainly attributable to secondary aneurysm sac rupture (13 deaths [7%] in EVAR vs two [1%] in open repair), with increased cancer mortality also observed in the EVAR group,” the authors wrote.

Lead author Dr. Roger Greenhalgh, of the Imperial College London, said aneurysms in the EVAR group could refill if the stent graft slips over time as patients’ blood vessels widen with age.

“What appears to be happening is that the device inserted into the aorta can move slightly over time. This allows tiny leaks to occur. Over time, these leaks cause a pressure build-up in the original aneurysm, which is then at risk of bursting. However, if patients were regularly scanned, these aneurysms could be caught in time,” Greenhalgh said.

Although newer stent grafts and 3D imaging have improved EVAR since the study launched in 2004, regular screening is a must, he added.

“These findings need to be a wake-up call to doctors across the world. Many of these aneurysms could have been caught with regularly scanning, such as ultrasound scanning. Therefore we should be scanning patients who undergo the EVAR procedure at least once a year, rather than the current situation where patients receive scans far less often,” Greenhalgh said. “The vast majority of aneurysm repairs performed in the world are EVAR procedures, and we are certainly not recommending switching back to the open operation. This involves a large incision in the body and carries serious risks.”

Filed Under: Clinical Trials, Stent Grafts, Vascular

More recent news

  • Medtronic earns CE mark for redo TAVI procedure
  • Natus Neuro launches BrainWatch AI-driven, point-of-care EEG
  • Boston Scientific has positive real-world Acurate Prime TAVI data
  • Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures
  • Onward reports more successful BCI implants

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy